0001013606-19-000172.txt : 20191001 0001013606-19-000172.hdr.sgml : 20191001 20191001163146 ACCESSION NUMBER: 0001013606-19-000172 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190927 FILED AS OF DATE: 20191001 DATE AS OF CHANGE: 20191001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Onopchenko John CENTRAL INDEX KEY: 0001403100 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28440 FILM NUMBER: 191129510 MAIL ADDRESS: STREET 1: C/O VOLCANO CORPORATION STREET 2: 11455 EL CAMINO REAL, SUITE 460 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOLOGIX INC /DE/ CENTRAL INDEX KEY: 0001013606 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680328265 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9495984741 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: RADIANCE MEDICAL SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19990122 FORMER COMPANY: FORMER CONFORMED NAME: CARDIOVASCULAR DYNAMICS INC DATE OF NAME CHANGE: 19960506 4 1 wf-form4_156996188341992.xml FORM 4 X0306 4 2019-09-27 0 0001013606 ENDOLOGIX INC /DE/ ELGX 0001403100 Onopchenko John 2 MUSICK IRVINE CA 92618 1 1 0 0 CEO and Director Option to Purchase 53.0 2019-09-27 4 D 0 19034 D 2018-10-30 2027-10-30 Common Stock 19034.0 0 D Option to Purchase 43.6 2019-09-27 4 D 0 19864 D 2019-05-02 2028-05-02 Common Stock 19864.0 0 D Option to Purchase 4.71 2019-09-27 4 A 0 12968 A 2020-09-10 2026-09-10 Common Stock 12968.0 12968 D Twenty-five percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter. The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 19,034 shares of common stock granted to the reporting person on October 30, 2017, and (ii) an option for 19,864 shares of common stock granted to the reporting person on May 2, 2018. In exchange, the reporting person received a new stock option, for 12,968 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019. One-third of the options vested on May 2, 2019 and the remaining balance was scheduled to vest in equal annual installments thereafter. The options vest in three equal annual installments over a three-year period commencing on September 10, 2019. John Onopchenko by Timothy N. Brady Attorney-in-Fact for Reporting Person 2019-10-01